Benitec Ltd   Report issue

For profit Phase 2
Founded: Melbourne VIC Australia (2001)

Organization Overview

First Clinical Trial
2018
NCT03433027
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Benitec BioPharma Ltd

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: Benitec Ltd (1) Acquired (1)

bb-401 (1 trial)

tt-034 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2